SUNSTONE LIFE SCIENCE VENTURES FUND II K/S Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SUNSTONE LIFE SCIENCE VENTURES FUND II K/S.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SUNSTONE LIFE SCIENCE VENTURES FUND II K/S. SUNSTONE LIFE SCIENCE VENTURES FUND II K/S is a 10% Owner in Egalet Corp ($EGLT).

Address: LAUTRUPSGADE 7 5TH FLOOR COPENHAGEN O DK-2100Denmark

Companies in which SUNSTONE LIFE SCIENCE VENTURES FUND II K/S is an Insider

Zyla Life Sciences

Trading Symbol: EGLT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SUNSTONE LIFE SCIENCE VENTURES FUND II K/S: 10% Owner
Holdings: 1,859,615 shares
Current Value: $8,479,844
Latest Transaction: Feb 12 2014
$EGLT Market Capitalization: $112.49M
$EGLT Previous Close: $4.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of SUNSTONE LIFE SCIENCE VENTURES FUND II K/S

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 12 2014EGLTEgalet CorpSUNSTONE LIFE SCIENCE VENTURES ...10% OwnerOption ExerciseX0.0096,000960
Feb 12 2014EGLTEgalet CorpSUNSTONE LIFE SCIENCE VENTURES ...10% OwnerOption ExerciseC0.00736,82600
Feb 12 2014EGLTEgalet CorpSUNSTONE LIFE SCIENCE VENTURES ...10% OwnerOption ExerciseC0.00416,81200
Feb 12 2014EGLTEgalet CorpSUNSTONE LIFE SCIENCE VENTURES ...10% OwnerBuyP12.00133,3331,599,9961,859,6151.7 M to 1.9 M (+7.72 %)
Feb 12 2014EGLTEgalet CorpSUNSTONE LIFE SCIENCE VENTURES ...10% OwnerBuyC6.00273,9861,643,9161,726,2821.5 M to 1.7 M (+18.87 %)
Feb 12 2014EGLTEgalet CorpSUNSTONE LIFE SCIENCE VENTURES ...10% OwnerBuyC6.00202,6581,215,9481,452,2961.2 M to 1.5 M (+16.22 %)
Feb 12 2014EGLTEgalet CorpSUNSTONE LIFE SCIENCE VENTURES ...10% OwnerBuyX0.0096,000961,249,6381.2 M to 1.2 M (+8.32 %)

View all SUNSTONE LIFE SCIENCE VENTURES FUND II K/S insider transactions.